Cutaneous tuberculosis and pyoderma gangrenosum.
Matsui
M
M
Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, and Department of Dermatology, Osaka Red Cross Hospital, Osaka, Japan.
Ohtoshi
E
E
Yamaoka
J
J
Matsuyoshi
N
N
Ohta
K
K
Toda
K
K
Horiguchi
Y
Y
Imamura
S
S
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005533:Foot Dermatoses / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D012293:Rifampin / Q000627:therapeutic use; D014382:Tuberculosis, Cutaneous / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology
D000904:Antibiotics, Antitubercular; D007538:Isoniazid; D012293:Rifampin